CORRECTION article

Front. Oncol., 03 July 2025

Sec. Head and Neck Cancer

Volume 15 - 2025 | https://doi.org/10.3389/fonc.2025.1649567

Correction: Case Report: Remarkable and sustained remission of an anaplastic thyroid carcinoma patient to the combined treatment of multimodal radiotherapy, anlotinib and toripalimab

  • 1. Thoracic Oncology Ward, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China

  • 2. Department of Oncology, Minda Hospital of Hubei Minzu University, Enshi, China

  • 3. Division of Thyroid Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China

  • 4. Head and Neck Oncology Ward, Cancer Center, West China Hospital, Sichuan University, Chengdu, China

In the published article, there was a mistake in the author affiliation.

Author Xuehu Wu was erroneously assigned to affiliation “Division of Thyroid Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China”. This affiliation has now been removed for author Xuehu Wu.

Affiliation “Department of Oncology, Minda Hospital of Hubei Minzu University, Enshi, China” was omitted for author Xuehu Wu. This affiliation has now been added for author Xuehu Wu.

Author Xin Wu was erroneously assigned to affiliation “Department of Oncology, Minda Hospital of Hubei Minzu University”. This affiliation has now been removed for author Xin Wu.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

anaplastic thyroid carcinoma, antiangiogenic drug, multimodal radiotherapy, immunotherapy, sustained remission anaplastic thyroid carcinoma

Citation

Xing Y, Wu X, Li Z and Wu X (2025) Correction: Case Report: Remarkable and sustained remission of an anaplastic thyroid carcinoma patient to the combined treatment of multimodal radiotherapy, anlotinib and toripalimab. Front. Oncol. 15:1649567. doi: 10.3389/fonc.2025.1649567

Received

18 June 2025

Accepted

20 June 2025

Published

03 July 2025

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

15 - 2025

Updates

Copyright

*Correspondence: Xin Wu,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics